Eisai
4523.T
#1963
Rank
NZ$14.27 B
Marketcap
$50.65
Share price
1.30%
Change (1 day)
-27.96%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.81. In 2022 the company made an earnings per share (EPS) of $2.80 a decrease over its 2021 EPS that were of $12.42.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5426.53%
2022$2.80-77.48%
2021$12.42-41.88%
2020$21.37-0.94%
2019$21.5752.59%
2018$14.14124.17%
2017$6.31-49.42%
2016$12.4737.08%
2015$9.10-11.75%
2014$10.31-3.23%
2013$10.65-18.56%
2012$13.08-15.51%
2011$15.48-3.75%
2010$16.09-1.36%
2009$16.31